EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells

Nimeet Desai, Uzma Hasan, Jeyashree K, Rajesh Mani, Meenakshi Chauhan, Suparna Mercy Basu, Jyotsnendu Giri

Acta Biomaterialia · 2023-04 · 161 · 1-36

DOI: 10.1016/j.actbio.2023.03.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2023-04. Verfasst von Nimeet Desai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Telangana, India. Hauptthemen laut MEDLINE: Biocompatible Materials, Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 257 Literaturangaben. Gefördert von: India Ministry of Science & Technology Department of Science and Technology, Impacting Research Innovation and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy involves the therapeutic alteration of the patient's immune system to identify, target, and eliminate cancer cells. Dendritic cells, macrophages, myeloid-derived suppressor cells, and regulatory T cells make up the tumor microenvironment. In cancer, these immune components (in association with some non-immune cell populations like cancer-associated fibroblasts) are directly altered at a cellular level. By dominating immune cells with molecular cross-talk, cancer cells can proliferate unchecked. Current clinical immunotherapy strategies are limited to conventional adoptive cell therapy or immune checkpoint blockade. Targeting and modulating key immune components presents an effective opportunity. Immunostimulatory drugs are a research hotspot, but their poor pharmacokinetics, low tumor accumulation, and non-specific systemic toxicity limit their use. This review describes the cutting-edge research undertaken in the field of nanotechnology and material science to develop biomaterials-based platforms as effective immunotherapeutics. Various biomaterial types (polymer-based, lipid-based, carbon-based, cell-derived, etc.) and functionalization methodologies for modulating tumor-associated immune/non-immune cells are explored. Additionally, emphasis has been laid on discussing how these platforms can be used against cancer stem cells, a fundamental contributor to chemoresistance, tumor relapse/metastasis, and failure of immunotherapy. Overall, this comprehensive review strives to provide up-to-date information to an audience working at the juncture of biomaterials and cancer immunotherapy. STATEMENT OF SIGNIFICANCE: Cancer immunotherapy possesses incredible potential and has successfully transitioned into a clinically lucrative alternative to conventional anti-cancer therapies. With new immunotherapeutics getting rapid clinical approval, fundamental problems associated with the dynamic nature of the immune system (like limited clinical response rates and autoimmunity-related adverse effects) have remained unanswered. In this context, treatment approaches that focus on modulating the compromised immune components within the tumor microenvironment have garnered significant attention amongst the scientific community. This review aims to provide a critical discussion on how various biomaterials (polymer-based, lipid-based, carbon-based, cell-derived, etc.) can be employed along with immunostimulatory agents to design innovative platforms for selective immunotherapy directed against cancer and cancer stem cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biocompatible MaterialsNeoplasmsHumansImmunotherapyNeoplastic Stem CellsLipidsTumor Microenvironment

Stichwörter der Autor:innen

BiomaterialsCancer immunotherapyCancer stem cellsImmune modulationImmune targeting

Substanzen

Biocompatible MaterialsLipids

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Telangana, India.
  • Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Telangana, India; Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India.
  • Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Telangana, India. Electronic address: jgiri@bme.iith.ac.in.

Förderung

  • India Ministry of Science & Technology Department of Science and Technology
  • Impacting Research Innovation and Technology

Zitieren

APA

Desai, N., Hasan, U., K, J., Mani, R., Chauhan, M., Basu, S. M., & Giri, J. (2023). Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells. Acta Biomaterialia, 161, 1-36. https://doi.org/10.1016/j.actbio.2023.03.004

Vancouver

Desai N, Hasan U, K J, Mani R, Chauhan M, Basu SM, et al. Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells. Acta Biomaterialia. 2023;161:1-36. doi:10.1016/j.actbio.2023.03.004

BibTeX
@article{Desai2023,
  author = {Desai, Nimeet and Hasan, Uzma and K, Jeyashree and Mani, Rajesh and Chauhan, Meenakshi and Basu, Suparna Mercy and Giri, Jyotsnendu},
  title = {Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells},
  journal = {Acta Biomaterialia},
  year = {2023},
  volume = {161},
  pages = {1--36},
  doi = {10.1016/j.actbio.2023.03.004}
}
Kostenlos starten →